Overall rank by patents
#11,159
of 50,000 tracked assignees
USPTO PatentsView assignee record - 27 granted patents across 31 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H10H (INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS).
The verdict
According to USPTO PatentsView, ams-osram ranks #11,159 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 31 technology areas.
Ams-osram International Gmbh has been granted 27 US utility patents between 2023 and 2025, placing Ams-osram International Gmbh at #11,159 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in H10H (INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS). As a Foreign Corporation, Ams-osram International Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, ams-osram sits between Yokogawa TEST & Measurement Corporation (27 patents, rank #11,515) and Access Medical Systems, Ltd. (26 patents, rank #11,523) - the closest US assignees by grant volume. The composite Innovation Score of 61.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2023 through 2025, with 27 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Ams-osram International Gmbh's 16.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 31 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
YOKOGAWA TEST & MEASUREMENT CORPORATION
27 patents
ZETTASET, INC.
27 patents
ZHEJIANG NHU CO., LTD.
27 patents
Zapadoceska univerzita v Plzni
27 patents
eyeSight Mobile Technologies Ltd.
27 patents
nference, Inc.
27 patents
tZERO IP, LLC
27 patents
ams-OSRAM International GmbH
27 patents
ACCESS MEDICAL SYSTEMS, LTD.
26 patents
What this shows Ams-osram holds 27 patents at rank #11,519, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,519 in granted patent volume.
Other assignees with the most granted patents in Ams-osram's primary technology class.
ams-osram's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 3.7% |
| 2024 | 8 | 29.6% |
| 2025partial year | 18 | 66.7% |
Top 15 of 31 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#11,159
of 50,000 tracked assignees
61.2 out of 100
How to use this portfolio
ams-osram's 27 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.